Asklepios Kliniken: Asklepios signs off on first-ever commercial paper program for EUR 500 million

EQS-News: Asklepios Kliniken

/ Key word(s): Financing

Asklepios Kliniken: Asklepios signs off on first-ever commercial paper program for EUR 500 million
21.12.2022 / 17:00 CET/CEST

The issuer is solely responsible for the content of this announcement.

Asklepios signs off on first-ever commercial paper program for EUR 500 million

  • Opening up new sources of debt capital
  • Strategic expansion of existing financing instruments

Hamburg, 21 December 2022. Asklepios Kliniken GmbH & Co. KGaA has signed off on the company’s first-ever commercial paper (CP) program for EUR 500 million, thus gaining access to an expanded financing market.

In the future, the CP program will enable the issuance of bearer bonds with terms of up to 364 days in the context of the Asklepios Group’s active liquidity management. The funds raised under the program will be used for general corporate financing.

“The adoption of the commercial paper program should be seen as part of the Asklepios Group’s long-term financing strategy,” says Hafid Rifi, Chief Financial Officer of the Asklepios Group. “Thanks particularly to the conclusion of syndicated loans and the issuance of multiple Schuldschein loans, Asklepios has broad access to the banking and promissory note markets. With the commercial paper program, we are opening up new sources of financing in the short-term range and are thus even better prepared for future macroeconomic challenges,” Rifi continues.

“With the CP program, we are expanding our financing options with a cost-effective and flexible debt capital instrument,” adds Benedikt Brörmann, Head of Corporate Finance & Treasury at Asklepios. “The program financially supplements our existing bilateral and syndicated credit lines and applies the standards of the International Capital Market Association (ICMA) for documentation.”

The establishment of the commercial paper program was guided by Commerzbank AG, which served as the arranger. The dealers under the program are BNP Paribas, Commerzbank AG, DZ Bank AG Deutsche Zentral-Genossenschaftsbank, Landesbank Hessen-Thüringen and Landesbank Baden-Württemberg. Asklepios’s legal adviser was Linklaters LLP.

About Asklepios

Asklepios Kliniken is one of the leading private operators of hospitals and healthcare facilities in Germany. The hospital group stands for highly qualified care for its patients, with a clear commitment to medical quality, innovation and social responsibility. On this basis, Asklepios has been developing dynamically since it was founded over 35 years ago. The Group currently has around 170 healthcare facilities throughout Germany. These include acute care hospitals of all different care levels, university hospitals, specialist clinics, psychiatric facilities, forensic institutions, rehabilitation clinics, nursing homes and medical centres. In the 2021 financial year, over 3.5 million patients were treated at the Asklepios Group’s facilities. The company has more than 67,000 employees.

IR contact
Mirjam Constantin
Head of Group ESG & Sustainability/ Manager Investor Relations
Asklepios Kliniken GmbH & Co. KGaA
Debusweg 3 – 61462 Königstein-Falkenstein
Tel.: +49 61 74 90-1166
ir@asklepios.com

PR contact
Rune Hoffmann
Head of Corporate Communications & Marketing
Asklepios Kliniken GmbH & Co. KGaA
Rübenkamp 226 – 22307 Hamburg
Tel.: +49 40 1818-82 6630
presse@asklepios.com

Visit Asklepios online, on Facebook or on YouTube:

www.asklepios.com
gesundleben.asklepios.com
www.facebook.com/asklepioskliniken
www.youtube.com/asklepioskliniken
Pflege-Blog: „Wir sind Pflege

 


21.12.2022 CET/CEST Dissemination of a Corporate News, transmitted by EQS News – a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


show this